Etiology and Clinical Course of Syphilis
Syphilis is a severe infectious disease caused by the specific microorganism Treponema pallidum. Understanding the routes of transmission is critical for selecting treatment tactics. The primary route of infection is sexual contact. However, transplacental transmission is equally important. In this case, the pathogen passes from an infected mother to the developing fetus, leading to congenital syphilis—a condition requiring specialized medical management.
The clinical course of the disease is characterized by distinct stages. Depending on the duration of infection and the host immune response, there are several sequential stages: primary, secondary, latent (asymptomatic), and tertiary syphilis. Each stage is taken into account when prescribing therapeutic regimens.
Basic Principles of Therapy and Classification
The treatment of syphilis is a strictly regulated process. Therapy is always carried out according to specialized, officially approved medical protocols. The core principle of treatment is its comprehensive nature, which is based on two main directions:
- Etiotropic treatment. Antibacterial agents form the basis, with the objective of directly eliminating the infectious pathogen from the patient's body.
- Enhancing resistance. Specialized agents that influence immunological resistance are included in the combination regimen to help the body fight the infectious agent.
From a pharmacological classification perspective, all antisyphilitic agents are traditionally divided into two large groups: antibiotics and synthetic compounds.
Tactics for Selecting Antibacterial Agents
When prescribing etiotropic therapy, clinicians follow a clear algorithm for drug selection.
Drugs of choice (first-line agents) are unconditionally recognized as benzylpenicillin group antibiotics. Their main advantage is high clinical efficacy across absolutely all stages of the disease. Benzylpenicillin preparations are administered in systemic courses, the parameters of which depend on the specific clinical presentation.
In clinical practice, situations arise where first-line therapy cannot be used due to individual hypersensitivity or allergy to penicillin. In such cases, alternative agents (reserve drugs) are prescribed. Antibiotics belonging to other pharmacological classes are used as reserve therapy. The most sought-after in this role are macrolides or cephalosporins, which are also capable of effectively suppressing Treponema pallidum.
Synthetic Agents: Bismuth and Arsenic Compounds
Historically important groups include synthetic antisyphilitic agents, specifically bismuth and arsenic preparations. In modern medicine, they are used extremely rarely. Previously, they were actively utilized for treating various forms of syphilis, predominantly in combination with penicillin antibiotics.
The mechanism of action of these synthetic compounds is based on the blockade of sulfhydryl (-SH) groups of enzymes in microbial cells. This enzymatic blockade disrupts the normal metabolic processes of the pathogen, leading to its death. These drugs are administered intramuscularly.
The abandonment of widespread bismuth and arsenic use is associated with their pronounced adverse effects:
- Bismuth preparations specifically affect mucous membranes, causing oral cavity lesions (gingivitis and stomatitis).
- Arsenic preparations exhibit high toxicity to internal organs: they cause liver damage (jaundice, toxic hepatitis) and negatively affect the nervous system (polyneuritis).